[ Back ]

Numab U.S.

numab.com
PO Box 902
Northboro, MA 01532

Company Info

Year Established
2011

Contacts

David Urech
CEO

Roland Helfenstein
CFO

Mireia Gomez-Angelats
CBO

Company Description

Numab is developing multi-specific antibody-based immunotherapies for inflammation and cancer. Reproducible plug-and-play therapeutic design process.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.